Becton, Dickinson and Co. | BDX - Current Assets



Becton, Dickinson and Co. reported $9B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Abbott USD 24.47B 1.32B Jun/2025
Agilent USD 4.25B 45M Jul/2025
Align Technology USD 2.45B 46.03M Jun/2025
Avanos Medical USD 356M 3.6M Jun/2025
Baxter International USD 7.04B 1.82B Mar/2025
Becton, Dickinson and Co. USD 9B 331M Jun/2025
Bio-Rad Laboratories USD 2.81B 225.5M Jun/2025
Boston Scientific USD 7.34B 415M Mar/2025
Cooper Companies USD 2.14B 12.1M Jul/2025
Danaher USD 11B 1.47B Jun/2025
Dentsply International USD 1.97B 12M Jun/2025
Dexcom USD 5.03B 476.4M Jun/2025
Edwards Lifesciences USD 6.21B 72.7M Mar/2025
Exact Sciences USD 1.51B 137.52M Jun/2025
Globus Medical USD 1.73B 19.79M Jun/2025
Hologic USD 3.42B 212.7M Jun/2025
Insulet USD 2.28B 48.7M Jun/2025
Integra LifeSciences USD 1.14B 35.58M Jun/2025
Intuitive Surgical USD 12.47B 592.4M Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Masimo USD 1.27B 85.8M Jun/2025
Medtronic USD 23.81B 1.3B Apr/2025
Solventum Corp 3.21B 155M Jun/2025
Stryker USD 13B 19M Jun/2025
Tandem Diabetes Care USD 614.82M 48.62M Jun/2025
Teleflex USD 1.72B 184.95M Jun/2025
Terumo JPY 718.08B 5.42B Jun/2025
Thermo Fisher Scientific USD 24.58B 1.21B Jun/2025
Zimmer Biomet Holdings USD 5.05B 536.3M Jun/2025